SBA Academy: Challenges in Drug Discovery and Development

Module 1: Drug Discovery

CHF 150 per module for members of SBA, academia, CTI start-up

Introductory Keynote: Pharma R&D: Issues and Perspectives (Reto Naef, Novartis)

Target Identification & Drug Design: Bioinformatics, Structure-Activity Relation, Docking Characteristics (Angelo Vedani, Torsten Schwede, University Basel), Case Presentation (Wolfgang Guba, Roche)

Compound Screening: From Hit to Lead Optimization (Jörg Trappe, Novartis), Case Presentation (Marc Gitzinger, BioVersys)

Proof of Concept: Target Validation from Mice to Men (Thomas Rückle, Medicines for Malaria Venture), Case Presentation (Bettina Ernst, Preclin Biosystems)

Navigating IP Issues (Bernhard Hostettler, Consultant)

More information click here

Start Date 22.02.2013 - 09:00
Event End 22.02.2013 - 17:00
Location Technologiepark
Module 1: Drug Discovery

CHF 150 per module for members of SBA, academia, CTI start-up

Introductory Keynote: Pharma R&D: Issues and Perspectives (Reto Naef, Novartis)

Target Identification & Drug Design: Bioinformatics, Structure-Activity Relation, Docking Characteristics (Angelo Vedani, Torsten Schwede, University Basel), Case Presentation (Wolfgang Guba, Roche)

Compound Screening: From Hit to Lead Optimization (Jörg Trappe, Novartis), Case Presentation (Marc Gitzinger, BioVersys)

Proof of Concept: Target Validation from Mice to Men (Thomas Rückle, Medicines for Malaria Venture), Case Presentation (Bettina Ernst, Preclin Biosystems)

Navigating IP Issues (Bernhard Hostettler, Consultant)

More information click here